US OptionsDetailed Quotes

RXST250117C22500

Watchlist

0.00
0.000.00%

15min DelayClose Jan 6 09:30 ET

0.00High0.00Low

RxSight Stock Discussion

Meltyy

May 16, 2024 01:19

🔔 RA Capital Q1 ‘24* Holdings Released... 🐳

» Holdings: 75
» Holdings in Top 20: 70.21%
» Qtr over Qtr Change**: +21.81%
Top Holdings:
$Ascendis Pharma A/S (ASND.US)$
$Vaxcyte (PCVX.US)$
$Legend Biotech (LEGN.US)$
$Janux Therapeutics (JANX.US)$
$Aerovate (AVTE.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Evolent Health (EVH.US)$
$NewAmsterdam Pharma (NAMS.US)$
$RxSight (RXST.US)$
$TYRA BIOSCIENCES, INC. (TYRA.US)$
$Edgewise Therapeutics (EWTX.US)$
$4D Molecular Therapeutics (FDMT.US)$
$Biogen (BIIB.US)$
$PepGen (PEPG.US)$
...

Moomoo AI

Feb 5, 2024 04:22

The recent insider sale of RxSight shares and the absence of insider purchases over the last year raise concerns about the company's outlook. Despite significant insider ownership, the lack of insider buying does not inspire confidence in the company's prospects.

Trade Alert: Independent Director Of RxSight William Link Has Sold Stock

EmotionOutOfEquation

Jan 8, 2024 14:23

$RxSight (RXST.US)$ oww back in action now sold too early

EmotionOutOfEquation

Dec 15, 2023 18:26

$RxSight (RXST.US)$ 213 % runs looks good here priming to jump 🔥

EmotionOutOfEquation

Dec 14, 2023 12:38

$RxSight (RXST.US)$ bought few lets fo !

moom lives

Dec 13, 2023 07:31

Stocks making the biggest moves before the bell:

$Tesla (TSLA.US)$ — Shares fell 1.2% after U.S. safety regulators said Tesla will recall more than 2 million vehicles to fix issues with its driver assistance system. The electric vehicle maker will send out a software update to fix the problem, which impacts models Y, S, 3 and X produced between Oct. 5, 2012 and Dec. 7, 2023.
$Pfizer (PFE.US)$ — The biopharmaceutical stock dropped 7.4% after Pfizer issued full-year guidance for adjusted earnings ...

Moomoo AI

Dec 13, 2023 04:55

Investor confidence in RxSight appears bolstered by its high future revenue growth expectations and strong performance, resulting in a high P/S ratio. Investors seem willing to pay more for anticipated growth.

RxSight, Inc. (NASDAQ:RXST) Stocks Shoot Up 45% But Its P/S Still Looks Reasonable

Moomoo AI

Dec 12, 2023 04:54

The company seems well equipped to manage its cash burn, potentially securing more funds for its expansion with minimal dilution or borrowing. Revenue growth paints a bright future for the firm, while the slight reduction in cash burn isn't concerning, given its mid-term expenditure needs.

Here's Why We're Not Too Worried About RxSight's (NASDAQ:RXST) Cash Burn Situation

Moomoo AI

Nov 15, 2023 07:44

Despite recent insider selling, the insiders still own shares worth about US$105m, or 11% of the company. However, the absence of insider buying raises cautiousness about the stock's outlook.

RxSight Insider Lowered Holding By 68% During Last Year

Moomoo Breakfast US

Aug 9, 2022 07:38

Columns Today's pre-market stock movers: NVAX, MRNA, NCLH, MU and more

Gainers:
In reaction to earnings/guidance:
• $GoodRx (GDRX.US)$ +38.5%, $EDGIO (EGIO.US)$ +13.5%, $Lemonade (LMND.US)$ +10.7%, $Desktop Metal (DM.US)$ +8.5%, $ShockWave Medical (SWAV.US)$ +8.2%, $Pubmatic (PUBM.US)$ +8.1%, $Olaplex (OLPX.US)$ +7%, $Vivid Seats (SEAT.US)$ +6.4%, $Noble (NE.US)$ +6.3%, $Aspen Technology (AZPN.US)$ +5.4%, $AAON Inc (AAON.US)$ +5%, $Hudbay Minerals (HBM.US)$ +5%, $Vivint Smart Home (VVNT.US)$ +4.9%, $Vivint Smart Home (VVNT.US)$ +4...

No comment yet